NDC 71610-714 – Diphenoxylate Hydrochloride and Atropine Sulfate

Diphenoxylate Hydrochloride 2.5 mg/1; Atropine Sulfate .025 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CV

Product NDC71610-714

Product details

Brand name
Diphenoxylate Hydrochloride and Atropine Sulfate
Generic name
Diphenoxylate hydrochloride and atropine sulfate
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA213335
Marketed since
October 30, 2020
Listing expires
December 31, 2026
Pharmacologic class
Anticholinergic; Antidiarrheal; Cholinergic Muscarinic Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Diphenoxylate Hydrochloride and Atropine Sulfate →

Package NDC codes (6)

Package NDCDescriptionSince
71610-714-3030 TABLET in 1 BOTTLE (71610-714-30)Jun 12, 2023
71610-714-5360 TABLET in 1 BOTTLE (71610-714-53)Jun 12, 2023
71610-714-6090 TABLET in 1 BOTTLE (71610-714-60)Jun 12, 2023
71610-714-70120 TABLET in 1 BOTTLE (71610-714-70)Jun 12, 2023
71610-714-80180 TABLET in 1 BOTTLE (71610-714-80)Jun 12, 2023
71610-714-90240 TABLET in 1 BOTTLE (71610-714-90)Jun 12, 2023

Other Diphenoxylate Hydrochloride and Atropine Sulfate products